LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Decision (EU) 2022/1097 of 30 June 2022 establishing the equivalence, for the purpose of facilitating the right of free movement within the Union, of COVID-19 certificates issued by the Republic of Madagascar to the certificates issued in accordance with Regulation (EU) 2021/953 of the European Parliament and of the Council (Text with EEA relevance)

Commission Implementing Decision (EU) 2022/1097 of 30 June 2022 establishing the equivalence, for the purpose of facilitating the right of free movement within the Union, of COVID-19 certificates issued by the Republic of Madagascar to the certificates issued in accordance with Regulation (EU) 2021/953 of the European Parliament and of the Council (Text with EEA relevance)

Implementing Decision (EU) 2022/1097 · Decision · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

COVID-19 vaccination certificates issued by the Republic of Madagascar in accordance with the ‘vaksiny.gov.mg’ system shall, for the purpose of facilitating the right of free movement within the Union, be considered as equivalent to those issued in accordance with Regulation (EU) 2021/953.

Article 2

Open ↗

The Republic of Madagascar shall be connected to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953.

Article 3

Open ↗

This Decision shall enter into force on the day of its publication in the Official Journal of the European Union .

Other acts of the same type
Council Implementing Decision of 23 February 2026 on the appointment of the fifth full-time member of the Executive Board of the Authority for Anti-Money Laundering and Countering the Financing of TerrorismCommission Implementing Decision (EU) 2026/390 of 23 February 2026 concerning the extension of the action taken by the Dutch Ministry of Infrastructure and Water Management permitting the making available on the market and use of the biocidal product Vectobac WG in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2026) 980)Council Decision (CFSP) 2026/432 of 23 February 2026 amending Decision (CFSP) 2024/1484 concerning restrictive measures in view of the situation in RussiaCouncil Decision (CFSP) 2026/438 of 23 February 2026 amending Decision (CFSP) 2022/266 concerning restrictive measures in response to the illegal recognition, occupation or annexation by the Russian Federation of certain non-government controlled areas of UkraineCouncil Decision (CFSP) 2026/439 of 23 February 2026 amending Decision (CFSP) 2024/583 on a European Union maritime security operation to safeguard freedom of navigation in relation to the Red Sea crisis (EUNAVFOR ASPIDES)Commission Implementing Decision (EU) 2026/453 of 23 February 2026 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States (notified under document C(2026) 1298)Council Implementing Decision (EU) 2026/480 of 23 February 2026 amending Implementing Decision (EU) 2024/1447 as regards the additional financial contribution from SwedenCouncil Decision (EU) 2026/643 of 23 February 2026 on the signing of the Agreement between the European Union and the Swiss Confederation on the transfer of Passenger Name Record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crimeCommission Implementing Decision (EU) 2026/375 of 20 February 2026 on harmonised standards drafted in support of Regulation (EC) No 765/2008 of the European Parliament and of the Council setting out the requirements for accreditationCommission Implementing Decision (EU) 2026/377 of 20 February 2026 postponing the expiry date of the approval of Bacillus sphaericus 2362 serotype H5a5b, strain ABTS1743 for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2026/378 of 20 February 2026 not renewing the approval of etofenprox for use in biocidal products of product-types 8 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2026/380 of 20 February 2026 postponing the expiry date of the approval of propan-2-ol for use in biocidal products of product-types 1, 2 and 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next